NEW YORK, Nov. 19 (GenomeWeb News) - MS vision will serve as Ionalytics' European agent, providing sales and service support for the proteomics company's Selectra technology.
Under the agreement, MS Vision will market Ionalytics Selectra in Europefor the Applied Biosystems/MDS Sciex API 300, 365 and 3000.
According to Ionalytics, Selectra enhances mass-spectrometer performance by providing an additional dimension of ion separation. Based on FAIMS technology, the Selectra transmits a targeted subset of ions into a mass spectrometer, resulting in improved detection limits, increased selectivity and increased throughput.
Financial terms of the agreement were not disclosed.